[Federal Register Volume 90, Number 226 (Wednesday, November 26, 2025)]
[Notices]
[Page 54312]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-21164]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary

[Docket ID: DoD-2025-HA-0214]


Submission for OMB Review; Comment Request

AGENCY: The Office of the Assistant Secretary of Defense for Health 
Affairs (OASD(HA)), Department of Defense (DoD).

ACTION: 30-Day information collection notice.

-----------------------------------------------------------------------

SUMMARY: The DoD has submitted to the Office of Management and Budget 
(OMB) for clearance the following proposal for collection of 
information under the provisions of the Paperwork Reduction Act.

DATES: Consideration will be given to all comments received by December 
26, 2025.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.

FOR FURTHER INFORMATION CONTACT: Reginald Lucas, (571) 372-7574, 
[email protected].

SUPPLEMENTARY INFORMATION: Title; Associated Form; and OMB Number: 
TRICARE Retail Refunds User Account Access Request; OMB Control Number 
0720-0032.
    Type of Request: Extension.
    Number of Respondents: 300.
    Responses per Respondent: 4.
    Annual Responses: 1,200.
    Average Burden Per Response: 8 hours.
    Annual Burden Hours: 9,600.
    Needs and Uses: The information collection requirement is necessary 
to obtain and record refund amounts between the DoD and pharmaceutical 
manufacturers. The DoD quarterly provides pharmaceutical manufacturers 
with itemized utilization data on covered drugs dispensed to TRICARE 
beneficiaries through TRICARE retail network pharmacies. These 
manufacturers validate the refund amounts calculated from the 
difference in price between the Federal Ceiling Prices and the direct 
commercial contract sales price. Once the refund amounts are validated, 
the pharmaceutical manufacturers directly pay the Defense Health Agency 
Government account.
    Affected Public: Business or other for-profit.
    Frequency: On occasion.
    Respondent's Obligation: Voluntary.
    DOD Clearance Officer: Mr. Reginald Lucas.

    Dated: November 21, 2025.
Stephanie J. Bost,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2025-21164 Filed 11-25-25; 8:45 am]
BILLING CODE 6001-FR-P